#BerlinCures #BC007 #LongCovid
Update on BC007 availability:
Berlin Cures has had a new batch of BC007 produced. This batch is currently undergoing analytical work and quality control. The steps of this quality control are required by law and take time. 1/5
Update on BC007 availability:
Berlin Cures has had a new batch of BC007 produced. This batch is currently undergoing analytical work and quality control. The steps of this quality control are required by law and take time. 1/5
Only when all quality control steps have been successfully completed and documented, BC007 is allowed to be used in a clinical trial after regulatory approval. We expect the quality control process to be completed in autumn. 2/5
Berlin Cures will - if the batch can be released after the quality control - provide the eye clinic of University Erlangen with a sufficient quantity to conduct the local study in up to 30 patients with #LongCovid. 3/5
At the same time, Berlin Cures plans to conduct a study of #LongCovid at several international clinics in Europe to generate data, suitable for an accelerated approval process for the drug. 4/5
If positive signals have emerged from the studies in #LongCovid, it is conceivable that a study in #MECFS patients will also be considered. 5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
